BACIL PHARMA LTD. SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Dec 22 | Sep 22 |
|---|---|---|
| Promoters (Change:0.00) | 42.67% | 42.67% |
| FIIs (Change:0.00) | 0% | 0% |
| Mutual Funds (Change:0.00) | 0% | 0% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:0.00) | 0% | 0% |
| Non Institution (Change:-0.00) | 57.33% | 57.33% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in BACIL PHARMA LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
BACPHAR News
Frequently Asked Questions
What is the Share price of BACIL PHARMA LTD. (BACPHAR)?
Can I buy BACIL PHARMA LTD. (BACPHAR) shares?
How do I buy BACIL PHARMA LTD. (BACPHAR) from Angel One?
- Direct investment: You can buy BACIL PHARMA LTD. (BACPHAR) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to BACIL PHARMA LTD. (BACPHAR) shares.
In which sector do BACIL PHARMA LTD. (BACPHAR) belong?
About BACPHAR
Today's live share price for BACIL PHARMA LTD. is NSE: N/A, BSE: ₹ 5.32 with a current market capitalization of .
Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).
Read more
